other material
confidence high
sentiment positive
materiality 0.80
Spectral AI DeepView System outperforms burn physicians in validation study; FDA submission planned mid-2025
Spectral AI, Inc.
- DeepView sensitivity 86.6% vs burn physicians 40.8% at image-wise level; pixel-wise 81.9% vs 38.8%.
- Dice score 68.5% vs 39.2%; specificity 61.2% vs anticipated 36% (CJA 79.1%).
- Study enrolled 164 patients (115 adult, 49 pediatric) across U.S. burn centers; one of largest U.S. burn trials.
- Plans FDA De Novo submission by Q2 2025; targets clearance early 2026 and rapid commercialization.